Skip to main content

Advertisement

Log in

Gut microbiota and metabolic syndrome

  • Review
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Symbiosis is the result of the relationship between gut microbiota and human surfaces; in fact, it regulates many functions such as metabolic and protective ones. It is widely known that any changes in the microbes in gut microbiota (dysbiosis) and the regulation of mucosal and systemic host’s immunity have been linked to different diseases such as metabolic syndromes and associated disorders. Recent studies report an aberrant gut microbiota and an alteration of gut microbial metabolic activities in obese subjects, with an important influence of a number of human physiological functions. Most studies suggest that diet, especially the high-fat low-fiber western-style diet, dramatically impacts on gut microbiota composition and functions in those patients with metabolic syndrome. A deeper knowledge of a specific microbiota profile associated with increased risk of metabolic disease and its subsequent modification induced by prebiotics, probiotics or targeted antibiotics will be necessary for the development of new therapeutic approaches in the treatment of metabolic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kau AL et al (2011) Human nutrition, the gut microbiome and the immune system. Nature 474:327–336

    Article  PubMed  CAS  Google Scholar 

  2. Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249

    Article  PubMed  CAS  Google Scholar 

  3. Scarpellini E et al (2010) Gut microbiota and obesity. Intern Emerg Med Suppl 1:S53–S56

    Article  Google Scholar 

  4. Manco M, Putignani L, Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31:817–844

    Article  PubMed  CAS  Google Scholar 

  5. Backhed F et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718–15723

    Article  PubMed  Google Scholar 

  6. Ley RE et al (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023

    Article  PubMed  CAS  Google Scholar 

  7. Murphy EF et al (2010) Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59:1635–1642

    Article  PubMed  CAS  Google Scholar 

  8. Wu GD et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105–108

    Article  PubMed  CAS  Google Scholar 

  9. Cani PD et al (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091–1103

    Article  PubMed  CAS  Google Scholar 

  10. Ojetti V et al (2009) Rifaximin pharmacology and clinical implications. Expert Opin Drug Metab Toxicol 5:675–682

    Article  PubMed  CAS  Google Scholar 

  11. Delzenne NM et al (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7:639–646

    Article  PubMed  CAS  Google Scholar 

  12. Cani PD et al (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutri 90:1236–1243

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca D’Aversa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

D’Aversa, F., Tortora, A., Ianiro, G. et al. Gut microbiota and metabolic syndrome. Intern Emerg Med 8 (Suppl 1), 11–15 (2013). https://doi.org/10.1007/s11739-013-0916-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-013-0916-z

Keywords

Navigation